Compare CNSP & MF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNSP | MF |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 9.5M |
| IPO Year | 2019 | 2021 |
| Metric | CNSP | MF |
|---|---|---|
| Price | $5.22 | $14.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | 5.7K | ★ 133.9K |
| Earning Date | 05-15-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.90 | $5.07 |
| 52 Week High | $10.59 | $22.56 |
| Indicator | CNSP | MF |
|---|---|---|
| Relative Strength Index (RSI) | 42.31 | 51.57 |
| Support Level | $5.15 | $10.30 |
| Resistance Level | $5.53 | $15.71 |
| Average True Range (ATR) | 0.17 | 2.63 |
| MACD | -0.10 | -0.37 |
| Stochastic Oscillator | 17.56 | 26.18 |
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.